This article was nominated for deletion on 11 January 2018. The result of the discussion was keep.

This article is rated List-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects:

Pharmacology Low‑importance This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles Low This article has been rated as Low-importance on the project's importance scale. Companies Start‑class Low‑importance This article is within the scope of WikiProject Companies, a collaborative effort to improve the coverage of companies on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.CompaniesWikipedia:WikiProject CompaniesTemplate:WikiProject Companiescompany articles Start This article has been given a rating which conflicts with the project-independent quality rating in the banner shell. Please resolve this conflict if possible. Low This article has been rated as Low-importance on the project's importance scale. WikiProject Companies To-do: Here are some tasks awaiting attention: Article requests : Wikipedia:Requested articles/Business and economics/Companies Assess : Category:Unassessed company articles Copyedit : Category:Company articles needing attention Infobox : Category:Company articles needing infoboxes Maintain : Portal:Companies Stubs : Help expand stub articles located at Category:Company stubs Other : Tag company articles with the {{ portal|Companies}} template Tag company talk pages with the {{ WikiProject Companies}} project banner Answer requests for comments

(For future article expansion)

• Consensus from Controversy: Cambridge's Biosafety Ordinance and the Anchoring of the Biotech Industry http://maryannfeldman.web.unc.edu/files/2011/11/Consensus-from-Controversy_2008.pdf
• Biotech Players Lead a Boom in Cambridge http://www.nytimes.com/2013/01/02/realestate/commercial/biotech-players-lead-a-boom-in-cambridge.html
• Why Boston’s Life-Science Sector Is So Strong https://www.sparefoot.com/self-storage/blog/6608-life-science-sector-in-boston/
• How to build a biotech renaissance: MIT in Kendall Square http://news.mit.edu/2014/how-to-build-a-biotech-renaissance-mit-in-kendall-square
• World's Largest Biotech Hubs: Boston and the San Francisco Bay https://www.thebalance.com/boston-and-san-francisco-biotech-hubs-375641
• Five Reasons Why Cambridge Leads The Globe In BioPharma https://www.forbes.com/sites/petercohan/2013/09/06/five-reasons-why-cambridge-leads-the-globe-in-biopharma/#20491616638a

Natureium ( talk) 21:34, 22 January 2018 (UTC) reply